greeksoup/ stock research

Alkermes plc. (ALKS) Q3 FY2026 earnings: revenue $480 million, up 21.8% on the year

Alkermes plc. (ALKS) reported revenue of $480 million for Q3 FY2026, the quarter ended 30 September 2026, up 21.8% on the same quarter a year earlier. Net income was $16 million, down 80.3% on the year, and diluted earnings per share $0.09. The figures are the company's own, from the 10-Q it filed with the SEC on 3 November 2026.

Revenue
$480 million
+21.8% on the year · -3.2% on the quarter
Q4 FY2024Q3 FY2026
Operating margin
7.5%
22.6% a year earlier
Q4 FY2024Q3 FY2026
Net income
$16 million
-80.3% on the year · +3,150.9% on the quarter
Q4 FY2024Q3 FY2026
Diluted EPS
$0.09
-81.6% on the year
Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

What management said

Guidance figures: 16 kept.

  • Revenue and net income reported: Total revenues were $480.1 million against $394.2 million a year earlier. GAAP net income was $16.3 million against $82.8 million; diluted EPS was $0.09 against $0.49. Adjusted EBITDA was $120.1 million against $121.5 million.
  • LUMRYZ revenue and patient count: LUMRYZ revenues were $89.9 million, with about 4,100 patients on therapy at quarter end. The prior-year quarter had no LUMRYZ revenue.
  • Avadel costs within expense lines: GAAP cost of goods was $94.2 million, R&D $121.1 million and SG&A $208.5 million. Costs related to the acquisition of Avadel were $29.8 million in the quarter and $118.1 million for nine months.
Read the earnings call summary

Income statement (profit and loss)

$ millionQ3 FY2026Q2 FY2026Q3 FY2025On the quarterOn the yearLast 8 quarters
Revenue480496394-3.2%+21.8%
Cost of revenue94.298.151.6-4.0%+82.6%
Gross profit386398343-3.0%+12.6%
Gross margin80.4%80.2%86.9%
Research and development12111381.7+7.3%+48.2%
Selling, general and administrative209218172-4.2%+21.4%
Operating income36.018.489.1+96.3%-59.6%
Operating margin7.5%3.7%22.6%
Interest expense27.625.90.0+6.3%
Pre-tax income14.7-1.9101-85.4%
Income tax-1.6-2.418.0
Effective tax rate-10.5%n/a17.9%
Net income16.30.582.8+3,150.9%-80.3%
Net margin3.4%0.1%21.0%
Diluted EPS$0.09$0.00$0.49-81.6%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ3 FY2026Q2 FY2026Q3 FY2025On the quarterOn the yearLast 8 quarters
Operating cash flow93.5145102-35.6%-8.1%
Capital expenditure3.48.117.3-58.2%-80.4%
Free cash flow90.113784.4-34.3%+6.8%
Free cash flow margin18.8%27.6%21.4%
Cash from investing20.0-2.4-6.7
Cash from financing6.317.20.3-63.3%+1,905.7%
Depreciation and amortisation27.230.38.1-10.3%+236.1%
Share-based compensation26.731.124.7-14.1%+8.4%
Buybacks0.00.00.0
Diluted shares, weighted176m173m169m+1.7%+4.7%
Shares outstanding at period end168m168m165m+0.3%+1.8%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ3 FY2026Q2 FY2026Q3 FY2025On the quarterOn the yearLast 8 quarters
Shareholders' equity1,8651,8091,733+3.1%+7.6%
Debt1,5121,5250.0-0.9%
Operating lease liabilities65.862.065.0+6.1%+1.2%
Other liabilities993998531-0.4%+87.0%
Total liabilities and equity4,4364,3932,330+1.0%+90.4%
Fixed assets215218247-1.5%-12.9%
Goodwill593594n/a-0.3%
Intangible assets1,7421,761n/a-1.1%
Investments156180523-13.2%-70.1%
Cash and equivalents631512616+23.4%+2.4%
Receivables459456354+0.6%+29.5%
Inventory261299191-12.7%+36.7%
Other assets378372398+1.7%-4.9%
Total assets4,4364,3932,330+1.0%+90.4%

Questions

What was Alkermes plc.'s revenue in Q3 FY2026?

Alkermes plc. (ALKS) reported revenue of $480 million for Q3 FY2026, the quarter ended 30 September 2026, up 21.8% on the same quarter a year earlier.

How much did Alkermes plc. earn in Q3 FY2026?

Net income for Q3 FY2026 was $16 million, down 80.3% on the year, and diluted earnings per share $0.09.

When did Alkermes plc. report Q3 FY2026 results?

Alkermes plc. filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 3 November 2026.

Quarterly results, the last 20 quarters

Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023 †Q2 FY2023 †Q3 FY2023 †Q4 FY2023 * †Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue324279276252305288617381377350399378430307391394385393496480
Cost of revenue53.755.258.450.654.058.263.361.570.158.661.563.162.149.249.551.646.261.698.194.2
Gross profit271223218202251229554319307292338315368257341343338331398386
Gross margin83%80%79%80%82%80%90%84%81%83%85%83%86%84%87%87%88%84%80%80%
R&D98.496.092.910010563.868.264.973.967.659.659.958.271.877.481.793.0103113121
SG&A160145150153158168196156170180168150147172171172187265218209
Operating income2.4-26.6-34.5-60.6-20.6-11.028189.254.643.311010516313.893.089.158.1-48.318.436.0
Operating margin1%-10%-12%-24%-7%-4%46%23%14%12%28%28%38%4%24%23%15%-12%4%8%
Interest expense2.42.42.43.64.85.35.76.06.16.06.06.04.60.00.00.012.320.925.927.6
Pre-tax income0.2-45.0-33.2-67.4-21.7-11.328292.758.346.911711017025.510510160.4-61.9-1.914.7
Tax rate-285%n/an/an/an/an/a1%1%-175%17%19%16%14%12%17%18%18%n/an/a-11%
Net income0.9-35.9-30.1-64.0-28.3-41.823747.811336.891.492.414722.587.182.849.3-66.50.516.3
Net margin0%-13%-11%-25%-9%-15%38%13%30%11%23%24%34%7%22%21%13%-17%0%3%
Diluted EPS$0.01-$0.22-$0.18-$0.39-$0.18-$0.25$1.38$0.28$0.66$0.21$0.53$0.55$0.88$0.13$0.52$0.49$0.29-$0.40$0.00$0.09
Operating cash flow31.021.7-2.30.61.0-21.321699.710721.114681.619098.8150102170-16614593.5
Capital expenditure8.77.810.010.510.06.99.714.517.08.37.18.39.810.113.017.3n/a4.18.13.4
Free cash flow22.413.9-12.3-9.8-9.0-28.220685.390.212.813973.318188.713784.4n/a-17013790.1
Buybacksn/an/an/an/an/an/an/an/an/an/an/a116n/an/an/a0.0n/a27.70.00.0
Shares outstanding162m163m164m164m164m166m166m167m167m169m166m162m162m165m165m165m166m166m168m168m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 September 2026, filed 3 November 2026: the filing.